Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.
about
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesColocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2.Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonistTotal Internal Reflection with Fluorescence Correlation Spectroscopy: Nonfluorescent CompetitorsNanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activation.A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell deathLigand-receptor kinetics measured by total internal reflection with fluorescence correlation spectroscopy.Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity.Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivityMultifunctional nanorods serving as nanobridges to modulate T cell-mediated immunityNovel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.Heterogeneity reduces sensitivity of cell death for TNF-stimuli.Clock gene modulation by TNF-alpha depends on calcium and p38 MAP kinase signaling.Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexesATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyThe critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantation.The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex.Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2.The Met-196 -> Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression.Quantitative single-molecule localization microscopy combined with rule-based modeling reveals ligand-induced TNF-R1 reorganization toward higher-order oligomers.Bistability analyses of a caspase activation model for receptor-induced apoptosis.Tumor necrosis factor-α inhibitors alleviation of experimentally induced neuropathic pain is associated with modulation of TNF receptor expression.Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
P2860
Q24683018-2A05977D-7EBC-4317-ACD5-ED0B24A6F9C9Q24811065-B0467FD4-C611-4EE6-91D1-3DFA0CEC077CQ27649040-3B7A5A09-3BDF-48CD-84AD-E7ED320A2013Q29304399-E86C523E-6B77-4EE9-A128-B00F21D915FEQ34001710-4213CB18-B454-47DD-A6CF-194196A4A57FQ34081647-6ACE0AFF-11E0-4718-BABD-54670CD197A2Q34183652-4343EC18-B980-4D4D-B74D-14DA9637492CQ34244499-BA098F77-EE49-4DC9-B442-C57F7E09245DQ34390877-4F6B979A-F22D-4E9A-B796-08E184067161Q34973492-02E09519-CF8E-4749-8826-90994204E6F8Q37679496-C52C0514-DEA5-490A-ADEB-8A0E88296589Q38659118-75067DFD-CC70-46FE-AD6E-09CFABB0EAFBQ39181336-588C6E7D-162C-4C0E-88DC-2D3B4E8D7589Q39421348-42DF6525-51AD-4A65-BE49-BD0A90BFB36DQ39821981-D0DBA07E-45F4-4183-938A-D322226A5CF4Q40371730-9E33B234-F7ED-495B-B189-EA80EC533C47Q41504457-D2BA0837-56C1-437C-9335-1971E81F0CACQ42183099-19B4602B-A173-4766-AEBC-E02FF18547B3Q42323234-F699851C-CA41-4ADF-90A2-D637A9271ABCQ42585598-D8D26A94-0A12-4CFF-B339-8C39511B79EFQ42738684-99D2C3C2-6C35-49AF-A922-4775CD506FAAQ45168684-E6726CC7-150E-478C-B79D-E23ED0AC131CQ45278079-B8AACE65-7BA0-4C95-BD2C-0DBB41CBB2EBQ47316430-5F28F2FC-DDEB-4A17-B9A2-5F8E5F0BC5A9Q54200868-1C1DDD79-99D1-4376-853B-A3670257E412Q54288740-DB27B325-328E-4C9F-A3C8-1D0FF4DCD468Q55335193-3A6CC7B5-7D23-4136-849E-3848F9A0EEB6Q58781970-22DCCD47-142C-45F5-B92E-CC2A022B9F04
P2860
Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Control of receptor-induced si ...... f ligand/receptor interaction.
@en
Control of receptor-induced si ...... f ligand/receptor interaction.
@nl
type
label
Control of receptor-induced si ...... f ligand/receptor interaction.
@en
Control of receptor-induced si ...... f ligand/receptor interaction.
@nl
prefLabel
Control of receptor-induced si ...... f ligand/receptor interaction.
@en
Control of receptor-induced si ...... f ligand/receptor interaction.
@nl
P2093
P2860
P356
P1476
Control of receptor-induced si ...... f ligand/receptor interaction.
@en
P2093
Anja Krippner-Heidenreich
Fabian Tübing
Gudrun Zimmermann
Peter Scheurich
Susanne Bryde
Sylvia Willi
P2860
P304
44155-44163
P356
10.1074/JBC.M207399200
P407
P577
2002-09-04T00:00:00Z